glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Effects of Once-Weekly on Disease by KDIGO Risk Category in the SUSTAIN 6 SGLT2 Inhibitors and GLP-1 Receptor
Description
These effects occur largely in the gastrointestinal tract
References InfantRisk Center
Cost-utility of albiglutide versus insulin lispro, insulin glargine, and sitagliptin for the treatment of type 2 diabetes in the US
doi: 10.1146/annurev.ph.34.030172.000305
10.1038/nature25773
[DOI] [PMC free article] [PubMed] [Google Scholar] 844.Abuirmeileh A., Harkavyi A., Rampersaud N., Lever R., Tadross J.A., Bloom S.R
